Over the projection period, it is predicted that leading players around the world would conduct more research and development, fueling the market for in-vitro diagnostics. To fulfil the rising demand for diagnostics from providers including clinical laboratories and point-of-care diagnostic facilities, the major players have started to implement diagnostic testing automation. Rapid point-of-care technology have made it possible for facilities to automate processes and lower the amount of labour needed to process bigger volumes of samples.
The market for In-Vitro Diagnostics was anticipated to reach US$ 76,621.8 million in 2022 and grow at a CAGR of 5.3% during the following five years (2022-2030).
Top Companies in the In-Vitro Diagnostics Industry:
1) Sysmex Corp. makes and sells tools, supplies, and software for in vitro diagnostics. Within this industry, the business specialises in haematological supplies and machinery. In addition to providing in vitro diagnostics for applications like hemostasis and urinalysis, Sysmex also provides system support and upkeep services. Founded in 1968. Headquarters are in Hyogo, Japan, at 1-5-1. The GBPA was ratified by Sysmex and Roche on December 14, 2020, providing the foundation for their alliance, which they launched on January 1, 2021. The DSSA, TLSA, and IT Solutions Cooperation Agreement are all part of the GBPA, and the two businesses have pledged to work together to create a next-generation global alliance.
Sysmex Corp:
2) Siemens Healthineers: Built in 1847. Headquarters are at Germany's Erlangen. Diagnostic, therapeutic, laboratory, point-of-care, and clinical consulting services are all areas in which Siemens Healthineers AG operates. Equipment from the imaging category includes ultrasound, computed tomography, X-ray systems, and magnetic resonance imaging. To modify network infrastructure for its production facilities and its development and research labs and move towards a zero trust architecture that incorporates removing implicit trust whereas constantly verifying every stage of an online communication, Atos revealed in October 2022 that it had earned a seven-year contract with Siemens Healthineers, the market leader in medical devices.